Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
NCT02012985
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hyperoxaluria
Interventions
BIOLOGICAL:
Oxabact OC5 capsules
DRUG:
Placebo capsules
Sponsor
OxThera
Collaborators
[object Object]